Disease Info Card

Primary Malignant Neoplasm Of Brain

Information about Primary Malignant Neoplasm Of Brain: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Primary Malignant Neoplasm Of Brain

Most recent studies have shown that Primary Malignant Neoplasm Of Brain shares some biological mechanisms with anaplastic-astrocytoma, astrocytoma, brain-neoplasms, brain-tumor-primary, central-nervous-system-neoplasms, glioblastoma, glioblastoma-multiforme, glioma, lymphoma, malignant-glioma, malignant-neoplasm-of-brain, malignant-neoplasms, malignant-paraganglionic-neoplasm, medulloblastoma, neoplasm-metastasis, neoplasm-recurrence-local, neoplasms, nervousness, oligodendroglioma, tumor-progression.

Among the many pathways, these few ones have gauged particular interests from scientists studying Primary Malignant Neoplasm Of Brain, and have been seen in publications frequently: Angiogenesis, Autophagy, Cell Adhesion, Cell Cycle, Cell Death, Cell Growth, Cell Migration, Cell Proliferation, Dedifferentiation, Drug Resistance, Immune Response, Induction Of Apoptosis, Invasive Growth, Localization, Methylation, Oncogenesis, Pathogenesis, Secretion, Translation, Tropism

Quite a number of genes have been found to play important roles in Primary Malignant Neoplasm Of Brain, such as AKT1, BCL2L1, CDKN1A, EGF, EGFR, ERBB2, IL2, IL4, MTOR, MYC, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PTEN, TLR4, TP53, VEGFA. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.